A new brand of a drug named "SIPGLIP" molecule named Sitagliptin was to be launched. Sitagliptin, an anti-diabetic drug, is sold under the brand name Januvia and is used to treat Type 2 diabetes. In July this year, the drug lost its patent.
The brief here was to make the product stand out since it was coming into the market with various other brands.
Sitagliptin is a ‘wonder drug’ for type 2 Diabetes launched in 2006 by Merck. Sitagliptin, sold under the brand name Januvia, is the drug of choice used to treat high blood sugar levels caused by type-2 diabetes. Sitagliptin works by increasing levels of natural substances called incretins which help to control blood sugar by increasing insulin release, especially after a meal.
Since it is a chronic disease, a dosage tracker with 15 days was added to the design. A dosage tracker helps patients to mark the days they have taken the medicine.
Thank you for your time.
